AnaptysBio Inc (NASDAQ: ANAB) on Monday, soared 4.79% from the previous trading day, before settling in for the closing price of $14.60. Within the past 52 weeks, ANAB’s price has moved between $12.51 and $41.31.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 201.20% over the past five years. The company achieved an average annual earnings per share of -0.07%. With a float of $26.01 million, this company’s outstanding shares have now reached $30.43 million.
Let’s look at the performance matrix of the company that is accounted for 117 employees. In terms of profitability, gross margin is 95.8%, operating margin of -257.84%, and the pretax margin is -289.74%.
AnaptysBio Inc (ANAB) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of AnaptysBio Inc is 14.52%, while institutional ownership is 103.95%. The most recent insider transaction that took place on Dec 30 ’24, was worth 842,060. In this transaction Director of this company bought 65,184 shares at a rate of $12.92, taking the stock ownership to the 7,860,180 shares. Before that another transaction happened on Dec 31 ’24, when Company’s Director bought 13,268 for $12.93, making the entire transaction worth $171,513. This insider now owns 7,873,448 shares in total.
AnaptysBio Inc (ANAB) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -0.07% per share during the next fiscal year.
AnaptysBio Inc (NASDAQ: ANAB) Trading Performance Indicators
AnaptysBio Inc (ANAB) is currently performing well based on its current performance indicators. A quick ratio of 10.23 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.07, a number that is poised to hit -1.62 in the next quarter and is forecasted to reach -5.36 in one year’s time.
Technical Analysis of AnaptysBio Inc (ANAB)
AnaptysBio Inc (NASDAQ: ANAB) saw its 5-day average volume 0.68 million, a negative change from its year-to-date volume of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 60.98%. Additionally, its Average True Range was 1.58.
During the past 100 days, AnaptysBio Inc’s (ANAB) raw stochastic average was set at 9.69%, which indicates a significant decrease from 57.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.68% in the past 14 days, which was lower than the 104.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.29, while its 200-day Moving Average is $26.90. Nevertheless, the first resistance level for the watch stands at $16.06 in the near term. At $16.81, the stock is likely to face the second major resistance level. The third major resistance level sits at $17.64. If the price goes on to break the first support level at $14.48, it is likely to go to the next support level at $13.65. Assuming the price breaks the second support level, the third support level stands at $12.90.
AnaptysBio Inc (NASDAQ: ANAB) Key Stats
Market capitalization of the company is 508.77 million based on 30,429K outstanding shares. Right now, sales total 17,160 K and income totals -163,620 K. The company made 30,020 K in profit during its latest quarter, and -32,850 K in sales during its previous quarter.
